Page 1 of Clinical Trials for Imatinib, 515 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Recruiting
Pilot Study of Gleevec/Imatinib Mesylate (STI-571, NSC 716051) in Neurofibromatosis (NF1) Patient With Plexiform Neurofibromas
Last Updated: March 27, 2012
Condition(s): Neurofibromatosis; Neurofibromas
2
Completed
Study to Evaluate the Pharmacokinetic Characteristics of Luckyvec 400mg Tablet, in Healthy Subjects
Last Updated: January 5, 2011
Condition(s): Healthy Volunteer
3
Terminated
Glivec/Gleevec Pediatric (Age 1 to Less Than 4) PK Study in CML, Ph+ ALL Patients and Other Glivec/Gleevec® Indicated Hematological Disorders.
Last Updated: March 12, 2012
Condition(s): Chronic Myeloid Leukemia (CML); Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL); Other Glivec/Gleevec Indicated Hematological Disorders (HES, CEL, MDS/ MPN)
4
Recruiting
Suboptimal Study Comparing Nilotinib and Imatinib
Last Updated: April 18, 2012
Condition(s): Chronic Myelogenous Leukemia
5
Active, not recruiting
Imatinib in Combination With Dacarbazine and Capecitabine in Medullary Thyroid Carcinoma
Last Updated: December 15, 2011
Condition(s): Solid Tumor; Thyroid Cancer
6
Terminated
Study of Dose Escalation Versus no Dose Escalation of Imatinib in Metastatic Gastrointestinal Stromal Tumors (GIST) Patients
Last Updated: July 20, 2011
Condition(s): Gastrointestinal Stromal Tumors
7
Active, not recruiting
Phase III, Open-label Study of Nilotinib Versus Imatinib in GIST Patients
Last Updated: October 4, 2011
Condition(s): Gastrointestinal Stromal Tumor (GIST)
8
Completed
Everolimus in Combination With Imatinib in Patients With Glivec Refractory/Resistant Gastrointestinal Stromal Tumors
Last Updated: January 11, 2011
Condition(s): Gastrointestinal Stromal Tumors
9
Completed
Preoperative and Postoperative Imatinib Mesylate Study in Patients With c-Kit Positive GIST
Last Updated: August 4, 2011
Condition(s): Gastrointestinal Stromal Tumors
10
Terminated
Trial of Tasigna (Nilotinib) 400 mg Twice Daily Alone or With Gleevec (Imatinib Mesylate) 400 mg Daily for Patients With Advanced Gastrointestinal Stromal Tumor (GIST)
Last Updated: March 8, 2012
Condition(s): GIST; Metastatic Disease
11
Terminated
Efficacy of 400 Mg Versus 800 Mg Imatinib in Chronic Myeloid Leukemia in Chronic Phase Patients - TOPS (Tyrosine Kinase Inhibitor Optimization and Selectivity)
Last Updated: January 5, 2012
Condition(s): Leukemia, Myeloid, Chronic Phase
12
Terminated
Imatinib Mesylate, Busulfan, Fludarabine, and Antithymocyte Globulin for CML Patients
Last Updated: April 19, 2012
Condition(s): Leukemia
13
Active, not recruiting
Five Year Adjuvant Imatinib Mesylate (Gleevec®) in Gastrointestinal Stromal Tumor (GIST)
Last Updated: August 24, 2011
Condition(s): Gastrointestinal Stromal Tumor (GIST)
14
Completed
Imatinib Mesylate (Gleevec) and Docetaxel in Patients With Head and Neck Squamous Cell Cancer
Last Updated: July 28, 2011
Condition(s): Head and Neck Cancer; Squamous Cell Cancer
15
Completed
Efficacy of Imatinib Mesylate in Hypereosinophilic Syndromes
Last Updated: December 28, 2010
Condition(s): Hypereosinophilic Syndrome; Chronic Eosinophilic Leukemia; Chronic Idiopathic Hypereosinophilia
16
Active, not recruiting
Cisplatin, Pemetrexed, and Imatinib Mesylate in Malignant Mesothelioma
Last Updated: March 1, 2012
Condition(s): Mesothelioma
17
Completed
Study Comparing 12 Months Versus 36 Months of Imatinib in the Treatment of Gastrointestinal Stromal Tumor (GIST)
Last Updated: December 28, 2011
Condition(s): Sarcoma
18
Terminated
Proof of Concept Trial of Gleevec (Imatinib) in Active Diffuse Scleroderma
Last Updated: March 6, 2012
Condition(s): Scleroderma
19
Completed
Imatinib Mesylate in Treating Patients With Metastatic Melanoma
Last Updated: August 18, 2010
Condition(s): Melanoma; Skin Neoplasms
20
Completed
Use and Tolerability of Imatinib Mesylate (Gleevec) in Leukemia Patients
Last Updated: May 21, 2009
Condition(s): Leukemia

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Imatinib

Page 1 of Clinical Trials for Imatinib, 515 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About